ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985